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Abstract 
Adolescents and young adults (AYAs) must be considered in their social and 
developmental context as this is impacted by their chronic rheumatic musculoskeletal 
disease (RMD) which in turn affects its management and outcomes. Healthcare 
professionals (HCPs) have a role in helping support AYAs with RMD with their social 
development, particularly by supporting autonomy to make their own choices. This 
chapter discusses social development and the impact on, and of, RMD, including 
implications for disease course and management, and the importance of peer support. 
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Social development of AYA and the influence of RMD   
As discussed (see chapter 1 and 2) biological changes during adolescence interact 
with psychosocial development to set up a range of new behaviours not seen in 
childhood or often dealt with in paediatric care (1). These biopsychosocial interactions 
include puberty, neurological maturation, abstract thought, self-identity, peer 
identification and autonomy (2). The main factors of typical adolescent social 
development can be broadly categorised as ‘independence’, ‘emotional adjustment’ 
and ‘identity formation’ (3). By late adolescence and early adulthood, several 
developmental tasks should be in progress or achieved (2-4):  
• Emergence of autonomous behaviour and social independence; 
• Intimate relationships and secure friendships;  
• Experimentation with personal and sexual identity,  
• Self-development; 
• Emotional skills development;  
• Vocational capability, including financial independence.  
Chronic childhood-onset conditions often disrupt young peoples’ sense of normality 
and impair their capacity for social participation (5). This results in delayed social 
maturation leading to knock-on effects into adolescence and young adulthood, as AYA 
with RMD can feel misunderstood and stigmatized from an early age. The physical 
and psychosocial challenges experienced with RMD are particularly salient and 
difficult for AYAs compared to children and adults, because of peer pressure to “fit in”, 
cultural associations between youth and health, exposure to social stigmas around 
disability and limited experience in adjusting to adversity (4, 6). Some AYA with RMD 
can be at risk of experiencing social difficulties, due to physical and psychological 
effects of disease and its treatment, including disruptions and restrictions to daily life 
(7).   
Social functioning has been ranked as a top area impacted by RMD in those aged 16-
25, with this effect on their lives more important than pain/stiffness and functional 
impairments (8). Table 1 shows the range of social impacts due to RMD, meaning 
opportunities available for healthy peers can be missed in AYA. These negative social 
consequences occur during any point of the fluctuating disease course, even during 
disease inactivity, as a result of affected quality of life from symptomatology not directly 
driven by inflammation (9, 10). AYAs with RMD are often unable to achieve the same 
level of autonomy as healthy peers, as the shift in balance of independence is affected 
(2). There can be a reliance on parents for involvement in their treatment that is either 
driven by the young person not feeling confident in self-management or due to parents 
not letting go. 
Childhood illness may influence a typical child–parent interaction (see chapter 5) and 
parenting styles particularly in regard to fostering autonomy and independence (11). 
Parents’ and close others’ concerns can restrict activities and overprotect AYAs (12). 
This overprotection can have detrimental effects on achieving autonomy and hindering 
experimentation that results in completion of social development tasks.  
The main challenge for AYAs with RMD is achieving an identity not defined by their 
illness. This involves developing their ability to accomplish desired activities, 
experience positive relationships (6), manage pain, use social support, and live one 
day at a time (13). Otherwise AYAs can resent the restrictive impact of disease on 
limiting physical and social capacities, career opportunities and parent-hood goals 
(14). Adapting, planning and pacing activities are required to maintain social 
involvement and prevent additional pain and fatigue from exerting excessive energy 
when attempting to keep up with peers (15). Positive emotions and self-esteem can 
be maintained through acceptance of their abilities and limitations. HCPs should 
encourage a discussion on realistic goal setting e.g. SMART goals (Specific, 
Measurable, Attainable, Relevant, Time-bound). Despite the numerous barriers 
mentioned in this section, most AYAs with RMD are socially competent and 
comparable to healthy counterparts on social functioning, acceptance and behaviour 
(4, 7, 11), adjusting and coping quite well with the psychological and social sequelae 
of their RMD over time (15). 
Table 1: Effects of RMD, including disability and/or medications on typical social 
development in AYAs (4, 7, 11, 13, 14, 16-21): 
• Hindered development of independence, including delayed independent living; 
• Reduced self-esteem; 
• Affected self-confidence and heightened self-consciousness, resulting from 
side effects of medications impacting body image  (e.g. weight gain and hair 
loss); 
• Forced locus of control to be external, rather than internal; 
• Less opportunities for participation in social activities and consolidation of social 
skills, due to impact of pain, fatigue and reduced mobility; 
• Medication impeding daily activities, such as side-effects, medication times, 
administration, storage or restrictions due to interactions (e.g. alcohol intake 
and methotrexate); 
• Transport issues, e.g. relying on parents for transport when friends can use 
public transport self-sufficiently; 
• Feeling isolated and potentially bullied causing social anxiety, especially if 
experiencing long or multiple absences from school/university/work caused by 
ill health or healthcare utilisation;  
• Overprotective family and/or peers imposing restrictions; 
• Problematic relationships with friends, family and professionals; 
• Difficulties with intimate relationships, potentially due to additional pressure or 
guilt of having someone be concerned and caring for you; 
• Educational difficulties and subsequent greater problems with vocation, either 
in finding employment or experiencing discrimination; 
• Struggles with identity, as misrepresented self being defined by disease; 
• Restricted major life decisions, such as narrowed career options, threat to 
parenthood and/or travelling considerations; 
• Unable to be as spontaneous or experimental as peers, with disease-related 
anxiety caused by unpredictability of disease and side effects of treatment 
 
 
Social aspects of health behaviours, disease course and HCP management 
strategies for AYA with RMD 
During the AYA developmental stage, independent health behaviours begin and can 
be established as lifelong habits (22). Adolescent social development can lead to 
egocentric behaviour and a disregard for the consequences of their behaviour on 
others (2). This change in attitude and hindered forward planning, due to delayed 
neurological development (see chapter 1), can increase risk-taking health behaviour. 
The extent to which typical adolescent issues affect illness management and control 
will depend on how AYA balance competing priorities (20). For example, the need for 
social support and acceptance can tempt AYAs to give into peer pressure by 
undertaking exploratory behaviours (23) that can put RMD management at risk. These 
risky health behaviours can include chaotic, nutritionally poor eating habits, smoking, 
alcohol, drug use and sexual risk taking (20).  
Conversely, some AYA report being able to use their condition or medications as a 
convenient excuse not to participate in behaviours they don’t want to (23), with peer 
pressure lessened when the adverse effects were explained to peers. Treatment can 
be seen as both an opportunity for living a ‘normal’ life but also a threat to achieving 
this (24).  
Rheumatology HCPs have the unique, ongoing opportunity to assess social, mental 
and emotional functioning, in addition to physical outcomes, and intervene early in a 
non-psychiatric environment (11, 25). This should start once RMD diagnosis is 
confirmed with an initial comprehensive psychosocial assessment (see chapter 2 for 
other areas to monitor). During routine clinic visits, some patients may benefit from a 
more unstructured opportunity to express their illness experience but following a 
structured psychosocial screen such as HEEADSSS (see chapter 4) is useful for AYA 
and HCP alike.  
The importance of peer support for AYA with RMD  
Peer support through strong peer relations is vital during adolescence to promote 
typical social development (3, 13, 26), since friendships nurture self-development 
separate from familial identity. Peers offer practical, emotional and social support (21), 
and can facilitate adjustment to chronic disease, coping with pain/illness and 
adherence by reducing general and illness-related stress (23). They can increase 
optimism and alleviate feelings of social isolation, which can assist the adoption of 
healthy behaviours, disease management skills (25), and acceptance of help with 
disease management (27). Conversely problematic unsupportive relationships lead to 
increased distress and disease activity (26, 28), by being oppressive, underestimating 
the disease and not providing useful advice (29). Regardless of social network size, 
AYA primarily disclose their illness to family members and only to a few peers.  
Good support from peers is key to adjustment, whereas support from the wider 
network (e.g. teachers, employers and nurses) becomes more important when family 
functioning is less positive (27). Reasons for withholding and not seeking support can 
include fear of rejection, pity, perceptions of being seen as vulnerable or different, 
dismissal of their problems/concerns as unimportant or alternatively overreactions and 
limiting of social activities/involvement. Sometimes others do not perceive these AYAs 
as chronically ill (7) in part due to the fluctuating and invisible nature of disease or not 
understanding the emotional impact of coping with daily pain and taking medications 
(25). Disclosure can be influenced by (26, 30):  
• Perceived trust and familiarity,  
• Shared experience with illness/disability,  
• Visibility of the condition and practical needs,  
• Recipient’s anticipated response, and  
• Decision that disclosure is justified.  
It is important that appropriate information regarding RMD, and the specific impact it 
has on that young person including pain and mood, is shared with peers, school and 
work to enable appropriate support (25, 31). Greater support beyond educational 
attainment is needed (16, 17), such as focusing on finding and keeping employment 
(see Table 2 for resources). AYAs and parents can be supported to disclose 
information in an appropriate and stepwise manner depending on their preferences 
and needs. For example, with the YPs consent, the school nurse or university doctor 
should be fully notified, whereas teachers or employers could be given information on 
supporting the young person during absences or coping with critical events (20, 25). 
The healthcare team are in a position of authority and can facilitate this disclosure by 
examining how the organisation (school, university or work) and the content of the 
treatment can be modified according to the AYA’s lifestyle, suggesting dialogue for the 
young person to say, or providing supporting clinical letters of recommendation to 
schools or local authorities.  
Peer support from other AYA with similar RMDs can provide meaningful emotional and 
social support due to a shared understanding of living with a chronic unpredictable 
disease, reducing isolation and negating the problems in support from friends without 
a RMD diagnosis (32). This support can involve discussions around acknowledging 
and overcoming concerns for the future (education, occupation or relationships), 
strategies around taking medication, and developing positive lifestyles in terms of 
physical activity and psychological wellbeing through goal-setting and action-planning 
(33). This can be disease specific or regarding areas indirectly impacted such as 
school/work and social life. Support groups, peer mentorship, residential weekends 
and virtual forums provide opportunities for peer networking, sharing inner thoughts to 
strengthen self-development and self-management confidence (13, 21, 32).  
Moreover, many AYAs are more open to recommendations from near-peer mentors 
versus adult mentors or professionals and may see other young adults coping 
successfully with a similar diagnosis as a sign of hope, which increases motivation 
and confidence that they too can manage their illness (32). 
Summary 
It is extremely positive that many AYA are doing well with regard to psychosocial 
adjustment and are comparable to peers in several areas. However those at risk need 
to be identified and intervention measures introduced as early as possible (7, 11), as 
impact on behaviour and management of disease can still be profound. Therefore 
regular screening/discussions to assess the psychosocial burden impacting quality of 
life is important to personalise treatment (28). It is imperative to match the needs and 
preferences of the young person with the support provided (26), with HCPs providing 
a flexible and youth-friendly approach. 
 
Key clinical management points 
• Explore social functioning and support, screening for social issues and identify 
areas needing support and appropriate referral e.g. Nurse or Psychologist: 
o Follow HEEADSSS psychosocial interview (34) to assess social issues, and 
changes to a patient’s social situations that might  impact wellbeing. 
o Use brief screening questionnaires in clinic such as the Work and Social 
Adjustment Scale (35) to quickly assess impact of illness on functioning by 
assessing work, home management, leisure activities, and 
family/relationships, to highlight areas needing discussion and support. 
o Allow time for unstructured discussion and encourage questions to gain 
further understanding of their perceptions of impact and distress.  
o Decide whether to escalate beyond patient education and whether to refer 
to psychology, particularly if disease is active or severe. 
• Ensure the young person has routine access to a key worker (such as a Clinical 
Nurse Specialist, Special Educational Needs Co-ordinator or Social Worker), to 
develop appropriate education, health and care plans to support continued 
engagement with activities and/or return to school or work. 
• Signpost AYAs to further information and support from charities and other 
organisations for general information about living with RMD and further resources 
and support. 
• Enable peer-to-peer support with other AYAs with RMD and help the young person 
make connections through charities and organisations. 
• Encourage parents, family members and/or partners to be supportive in helping 
the young person gain independence and social contacts in line with typical AYA 
social development. 
• Engage AYAs in shared decision making regarding treatment options, including 
seeing the young person alone for a portion of the consultation, to encourage 
independence from parents and promote self-management. 
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